Audit of insulin pump therapy
Published Date: 19th July 2016
Publication Authors: Furlong NJ
Aims
The National Institute for Health and Clinical Excellence (NICE) published guidelines for the use of continuous subcutaneous insulin infusion in 2008 (technology appraisal 151). The first UK-wide insulin pump audit took place in 2012 with the aim of determining adherence to the guidance issued in NICE technology appraisal 151. The results of the adult service level audit are reported here.
Methods
All centres providing continuous subcutaneous insulin infusion services to adults with diabetes in the UK were invited to participate. Audit metrics were aligned to technology appraisal 151. Data entry took place online using a DiabetesE formatted data collection tool.
Results
One hundred and eighty-three centres were identified as delivering adult continuous subcutaneous insulin infusion services in the UK, of which 178 (97.3%) participated in the audit. At the time of the audit, 13 428 adults were using insulin pump therapy, giving an estimated prevalence of use of 6%. Ninety-three per cent of centres did not report any barriers in obtaining funding for patients who fulfilled NICE criteria. The mean number of consultant programmed activities dedicated to continuous subcutaneous insulin infusion services was 0.96 (range 0–8), mean whole-time equivalent diabetes specialist nurses was 0.62 (range 0–3) and mean whole-time equivalent dietitian services was 0.3 (range 0–2), of which 39, 61 and 60%, respectively, were not formally funded.
Conclusions
The prevalence of continuous subcutaneous insulin infusion use in the UK falls well below the expectation of NICE (15–20%) and that of other European countries (> 15%) and the USA (40%). This may be attributable, in part, to lack of healthcare professional time needed for identification and training of new pump therapy users.
White, HD; Furlong, NJ et al. (2014). The UK service level audit of insulin pump therapy in adults . Diabetic Medicine. 31 (4), 412-18
« Back